Inflammation  >>  bromfenac ophthalmic (ISV-101)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
bromfenac ophthalmic (ISV-101) / Sun Pharma
NCT01190878: Study to Compare Differing Dosing Regimens of ISV-303 (Bromfenac in DuraSite) to Xibrom and Vehicle in Post Cataract Surgery Volunteers

Completed
1/2
169
NA
ISV-303, DuraSite Vehicle, Xibrom™
Sun Pharmaceutical Industries Limited
Ocular Inflammation
01/11
01/11

Download Options